CSPG4 and cancer: We cocultured CSPG4-targeting CAR-Ms with cancer cells for 48 h, FACS-isolated these CAR-Ms (“primed”), and evaluated infiltrative ability and phagocytosis capacity compared to CAR-Ms that had not interacted with cancer cells (“non-primed”).